Calix, Inc. — Form 10-Q Summary
Reporting period: Third quarter ended October 1, 2022; comparisons are with the quarter ended October 2, 2021. Nine-month figures are for the respective year-to-date periods. Amounts below are in millions except per-share data and percentages.
Business context
Calix provides cloud and software platforms, network systems, and services to broadband service providers (BSPs). Systems sales remain the substantial majority of revenue. Management attributed growth primarily to increased demand from small and medium BSP customers adopting its platform offerings, plus shipments to a new medium-sized customer.
Financial results and position
| Metric | Q3 2022 | Q3 2021 | Nine months 2022 | Nine months 2021 |
|---|---|---|---|---|
| Revenue | $236.3 | $172.2 | $623.3 | $503.0 |
| Gross profit / margin | $118.6 / 50.2% | $89.5 / 52.0% | $310.5 / 49.8% | $265.4 / 52.8% |
| Operating income | $20.0 | $18.0 | $39.6 | $59.3 |
| Net income | $13.4 | $177.4 | $29.1 | $218.5 |
| Diluted EPS | $0.19 | $2.61 | $0.42 | $3.24 |
| Cash from operations | Not separately provided | Not separately provided | $21.1 | $44.2 |
- Revenue: Q3 increased 37%; nine-month revenue increased 24%. Systems revenue rose 38% in Q3 and 24% year to date. U.S. revenue represented 91% of Q3 revenue, versus 79% a year earlier.
- Margins and expenses: Q3 gross profit grew 32%, but overall gross margin fell 180 basis points; systems margin declined 220 basis points, chiefly from higher component and logistics costs. Operating expenses rose 38% in Q3 and 32% year to date, reflecting higher personnel, sales incentives, stock compensation, marketing, and other investment costs.
- Profit comparability: Prior-year net income included a substantial non-cash tax benefit from reversal of a deferred-tax-asset valuation allowance. The 2021 nine-month income-tax benefit was $159.6 million; the 2022 nine-month tax expense was $10.9 million. Thus reported net income and EPS comparisons are not representative of operating trends alone.
- Cash flow and liquidity: Nine-month operating cash flow was $21.1 million, down from $44.2 million. Inventory increased $52.2 million and prepaid expenses and other assets increased $32.9 million, partly offset by a $36.2 million increase in accounts payable. At October 1, cash and cash equivalents were $75.2 million and marketable securities were $159.5 million, totaling $234.7 million.
- Balance sheet: Current assets were $535.2 million and current liabilities $180.5 million; total liabilities were $219.1 million and equity $647.7 million. The balance sheet reports no borrowings; the company said it terminated its Bank of America loan and security agreement in January 2022.
Material changes, outlook, risks and contingencies
- Inventory rose to $141.1 million from $88.9 million at year-end 2021. Management said it increased inventory to improve responsiveness to demand amid prolonged component shortages and supply-chain delays.
- Outstanding supplier inventory purchase commitments were approximately $398.8 million, compared with $247.3 million at year-end 2021. The broader contractual-obligations table reports $428.9 million of non-cancelable purchase commitments, including $357.4 million due in less than one year. These commitments expose Calix to demand-forecasting, excess-inventory, and obsolescence risks.
- Management expects supply-chain delays and related challenges to persist for the foreseeable future. It expects sales and marketing and research and development spending to increase in absolute dollars; it expects general and administrative spending to increase in dollars but decline slightly as a share of revenue over time.
- Management believes available cash, investments, and expected operating cash flows will cover anticipated needs for at least the next 12 months. This assessment depends on execution of its operating plan and continued operating income and positive cash flow.
- The board authorized a one-year share repurchase program of up to $100 million in July 2022; no shares were repurchased through October 1, 2022.
- Remaining performance obligations were $173.1 million; the company expects to recognize 35% as revenue over the next 12 months. A revenue-share agreement carries a $15.8 million aggregate fixed-payment cap through March 2024; a true-up may be due if minimum payments are not achieved. The recorded liability, including accrued interest, was $12.7 million.
- Management identified risks including reliance on third-party manufacturers and limited-source components, elevated freight and component costs, COVID-related disruption, macroeconomic and geopolitical uncertainty, customer spending and adoption of new platforms, cybersecurity and privacy obligations, and inventory commitments. Management reported no pending litigation expected to have a material adverse effect and stated disclosure controls were effective at a reasonable-assurance level.
Important facts for investors to verify
- Whether revenue growth and the new customer’s shipments continue, and whether international revenue weakness persists.
- Whether higher supply-chain costs, logistics expenses, and product mix continue to pressure systems and overall gross margins.
- How inventory, supplier commitments, and prepaid supply-chain payments convert into shipments, revenue, and operating cash flow.
- Whether the company sustains operating income and positive cash generation while funding growth investments and any share repurchases.
- How deferred-tax-asset realizability and future effective tax rates affect reported earnings; the filing notes a $30.9 million valuation allowance remains on certain deferred tax assets.
- Whether the revenue-share minimums, supplier obligations, or other contingencies result in additional cash payments or charges.